New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.
Coronavirus Reinfection News | Live & Top Stories newsnow.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsnow.co.uk Daily Mail and Mail on Sunday newspapers.
Researchers at Washington University School of Medicine in St. Louis have discovered that the immune cells in the protective tissue surrounding the brain known as the meninges come primarily from the bone marrow of the skull. The findings lead to the possibility of developing therapies to target such cells to prevent or treat neurological conditions.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Pathline Expands Medical Team, Appoints Three New Physicians
May 3, 2021 GMT
RAMSEY, N.J. (BUSINESS WIRE) May 3, 2021
Pathline, a leading provider of specialized anatomic pathology services, has expanded its team with a new Chief Medical Officer, Director of Hematopathology and Molecular Pathology and Senior Pathologist. The recently appointed physicians include:
Gregory S. Henderson, M.D., Ph.D., F.C.A.P., F.A.S.C.P. - Chief Medical Officer
Bevan Tandon, M.D. - Director of Hematopathology and Molecular Pathology
Douglas Charney, M.D. - Senior Pathologist